C. Stephen Foster, M.D.
In Print (301-350)
301. Gregory JK, Foster CS. 1996. Peripheral Ulcerative Keratitis in the Collagen Vascular Diseases. Int. Ophthalmol. Clin. 36(1):21-30.
302. Nguyen QD, Foster CS. 1996. Cicatricial Pemphigoid: Diagnosis and Treatment. Int. Ophthalmol. Clin. 36(1):41-60.
303. Legmann A, Foster CS. 1996. Noninfectious Necrotizing Scleritis. Int. Ophthalmol. Clin. 36(1):73-80.
304. Ceisler EJ, Foster CS. 1996. Juvenile Rheumatoid Arthritis and Uveitis: Minimizing the Blinding Complications. Int. Ophthalmol. Clin. 36(1):91-107.
305. Smith JA, Foster CS. 1996. Sarcoidosis and Its Ocular Manifestations Int. Ophthalmol. Clin. 36(1):109-125
306. Bhisitkul RB, Foster CS. 1996. Diagnosis and Ophthalmological Features of Behået’s Disease. Int. Ophthalmol. Clin. 36(1):127-134.
307. Samiy N, Foster CS. 1996. The Role of Nonsteroidal Antiinflammatory Drugs in Ocular Inflammation. Int. Ophthalmol. Clin. 36(1):195-206.
308. Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS. 1996. Systemic Drug Toxicity Trends in Immunosuppressive Therapy of Immune and Inflammatory Ocular Disease. Ophthalmol. 103:768-775.
309. Bhol K, Mohimen A, Neumann R, Yunis J, Foster CS, Yunis EJ, Ahmed AR. 1996. Difference in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. Curr Eye Res. 15:521-532.
310. Foster CS. 1995. Revolutionary Discoveries Lead to Diagnosis and Cure. Ophthalmology World News; Contributor’s Corner. June 1995; p. 17.
311. Buhac J, Bhol K, Padilla T, Foster CS, Ahmed AR. 1996. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol; 34:884-6.
312. Soheilian M, Markomichelakis N, Foster CS. 1996. Intermediate Uveitis and Retinal Vasculitis: New Ocular Manifestations of Cat Scratch Disease, Am J Ophthalmol. 122(4):582-584.
313. Foster CS, Alter G, Crabb JL, DeBarge LR, Feiler L, Friedlander MH, Raizman MB, Santos CI. 1996. Efficacy and Safety of Rimexolone 1% Ophthalmic Suspension Versus Pred Forte 1% in the Treatment of Uveitis. Am J Ophthalmol. 122(2);171-182.
314. Power WJ, Saidman SL, Zhang DS, Vamvakas EC, Merayo-Lloves JM, Kaufman AH, Foster CS. 1996. HLA Typing in Patients with Ocular Manifestations of Stevens-Johnson Syndrome. Ophthalmol. 103(9):1406-1409.
315. Dutt JE, Ledoux D, Baer H, Foster CS. 1996. Collagen Abnormalities in Conjunctiva of Patients with Cicatricial Pemphigoid. Cornea. 15(6):606-611.
316. Neves RA, Rodriguez A, Power WJ, Muccioli C, Lane L, Belfort R, Foster CS. 1996. Herpes Zoster Peripheral Ulcerative Keratitis in Patients with the Acquired Immunodeficiency Syndrome. Cornea. 15(5): 446-450.
317. Dana M-R, Merayo-Lloves J, Foster CS. 1996. Prognosticators for Visual Outcome in Sarcoid Uveitis. Ophthalmol. 103(11):1846-1853.
318. Heiligenhaus A, Dutt JE, Foster CS. 1996. Histology and Immunopathology of Systemic Lupus Erythematosus Affecting the Conjunctiva. Eye. 10(Part 4):425-432.
319. Rojas B, Foster CS. 1996. Cataract Surgery in Patients with Uveitis. Cur Op Ophthalmol. 7(1):11-16.
320. Berra A, Heiligenhaus A, Foster CS. 1996. T cell subsets and T cell receptor VÐ utilization by Igh-1 congenic mice in herpetic retinal necrosis. Graefe’s Arch Clin Exp Ophthalmol. 234 Suppl 1:583-588.
321. Zierhut M, Bieber T, Bröcker E, Forrester J, Foster CS, Streilein W. 1996. Trends in Immunology. Immunology Today. 17(10):448-450.
322. Sainz de la Maza M, Foster CS, Jabbur NS. 1996. Scleritis-associated uveitis. Ophthalmol. 104(1):58-63.
323. Foster CS. 1996. Juvenile Rheumatoid Arthritis-Associated Uveitis: The Continuing Saga of Preventable Blindness. Ophthalmology Times.
324. Foster CS. 1996. Rimexolone is the first new corticosteroid for ophthalmic use in 20 years ð Its use controls inflammation without significantly raising intraocular pressure. Ocular Surgery News. 14(20):124-125.
325. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. 1997. Visual Outcomes Prognosticators in Juvenile Rheumatoid Arthritis-Associated Uveitis. Ophthalmol. 104(2):236-244.
326. Power WJ, Hogan RN, Hu S, Foster CS. 1996. Primary Varicella Keratitis: Diagnosis by PCR. Am J Ophthalmol. 123(2):252-254.
327. Abad JC, Foster CS. 1996. Fungal Keratitis. Int. Ophthal. Clin. 36(3):1-15.
328. Rojas B, Zafirakis P, Foser CS. 1996. Cataract Surgery in Patients with Uveitis. Cur Op Ophthalmol. 8(1):6-12.
329. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Hemler M, Foster CS, Ahmed AR. 1996. Ocular cicatricial pemphigoid antigen: Partial sequence and characterization. Proc. Soc. Nat. Sci. 93:14714-14719.
330. Sainz de la Maza M, Tarrus S, Foster CS. 1997. Tratamiento de la episcleritis recurrente. Arch Soc Esp Oftalmol. 72:17-22.
331. Sangwan VS, Zafirakis P, Foster CS, 1997. Mooren’s Ulcer. Indian Journal of Ophthalmology. 45(1):7-17.
332. Rodriguez A, Yood RA, Condon TJ, Foster CS. 1997. Recurrent Uveitis in a Patient with Adult-onset Cyclic Neutropenia Associated with Increased Large Granular Lymphocytes. Br J Ophthalmol. 81:415
333. Nussenblatt RB, Gery I, Ferris F, Weiner H, Shiloach J, Ramaley N, Perry C, Caspi R, Hafler D, Foster CS, Whitcup SM. 1997. Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial. Am J Ophthalmol. 123:583-592.
334. Yang J, Foster CS. 1997. Rimexolone: A new ophthalmic corticosteroid with low intraocular pressure raising potential. Drugs of Today. 33:123-129.
335. Foster CS. 1997. The Role of Ocular Immunology in the Twenty-First Century. Archivos de la Sociedad Espanola de Oftalmologia. 72:4.
336. Akpek EA, Merchant A, Pinar V, Foster CS, 1998. Ocular Rosacea. Patient Characteristics and Follow-Up. Ophthalmology 104:1863-1867.
337. Taravella MJ, Johnson DW, Petty JG, Keyser RB, Foster CS, Lundberg BE. 1997. Infectious Posterior Scleritis Caused By Pseudallescheria Boydii: Clinicopathologic Findings. Ophthalmol. 104:1312-16
338. Hu S, Dutt J, Zhao T, Foster CS. 1997 Tetrandrine potently inhibits herpes simplex virus type-2-induced keratitis in BALB/C mice. Oc. Immunol. Inflamm. 5:173-180.
339. Arrunategui-Correa V, Dutt JE, Foster CS. 1997. Analysis of T Cell Receptor Vb Gene Expression in B Cell Deficient Mice After Experimental Herpes Simplex Virus Keratitis. Acta Virologica 41:145-152.
340. Foster CS, 1997 Topical Steroid Treatment of Ocular Inflammation. Ophthalmol. Clin. N.A. 10:389-403.
341. Reza Dana M, Chatzistefanou K, Schaumberg DA, Foster CS. 1997. Posterior Capsule Opacification After Cataract Surgery in Patients with Uveitis. Ophthalmol. 104:1387-94.
342. Foster CS. 1997. A new steroid for treating postoperative opthalmic inflammation and uveitis. Ophthalmic Practice. 15:117-118.
343. Foster CS. 1996 Necrology of Dr. Garrett Sullivan. Trans. Am. Ophthalmol. Soc. 94:15-16.
344. Merchant A, Foster CS. 1997. Primary Intraocular Lymphoma (CNC-NHL). Int. Ophthalmol. Clin. 37(4):101-116.
345. Yang J, Foster CS. 1997. Squamous Cell Carcinoma of the Conjunctiva. Int. Ophthalmol. Clin. 37(4):73-86.
346. Merchant A, Fletcher J, Medina CA, Hemady R, Foster CS. 1997. Pharmacomanipulation of HSV-1 Induced Chorioretinitis in Mice. Eye. 11 (4) :504-505.
347. Hu S, Merayo-Lloves J, Zhao T, Foster CS. 1997. Potent Inhibitory Effect of Tetrandrine on Experimental Allergic Conjunctivitis in Mice. J. Ocular Pharmacol Therapeut. 13: 435-444.
348. Abad JC, An B, Power WJ, Foster CS, Azar DT, Talamo JH. 1997. A Prospective Evaluation of Alcohol-Assisted vs. Mechanical Epithelial Removal Before Photorefractive Keratectomy (PRK). Ophthalmol. 1997;104:1566-75.
349. Foster CS. 1998. Systemic Lupus Erythematosus, Discoid Lupus Erythematosus, and Progressive Systemic Sclerosis. Int. Oph. Clin. 37(2): 93-116.
350. Harper S, Foster CS. 1998. Rheumatoid Disease and the Eye. Int. Ophthalmol. Clin. 38(1):1-19.
 |
|
|
|
